Med-Aesthetic Solutions Inc entered the industry of Patent Medicines in 2005 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 424210, which describes it as a Patent Medicines. For further clarification, the SIC classifies this business under the code 5122 and described it as a Patent Medicines. The business provides service to the B2B market.
To acquire more information, please contact Thomas Obrien by calling (505) 341-2577 during business hours. You can also write to the business’ Single Location at 6808 Academy Parkway East Ne A1, Albuquerque, New Mexico NM 87109. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Med-Aesthetic Solutions Inc |
| Representative: | Thomas Obrien |
| Place of Business: | 6808 Academy Parkway East Ne A1, Albuquerque, NM 87109 |
| Contact Number: | (505) 341-2577 |
| Type of Service: | Patent Medicines |
| SIC Number: | 5122 |
| NAICS Number: | 424210 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2005 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Med-Aesthetic Solutions Inc is a company operating from Bernalillo, New Mexico providing professional Patent Medicines and relevant B2B variables. It was founded in 2005 and registered with the SIC code 5122 as Patent Medicines, and with the NAICS code 424210 as Patent Medicines.
With a current employee count of 1 to 4, Med-Aesthetic Solutions Inc has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Thomas Obrien at (505) 341-2577 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 6808 Academy Parkway East Ne A1 in Albuquerque, New Mexico 87109 and can be engaged online through the company website at , the company Twitter , and Facebook page .